Hospital-Based Management of Opioid Use Disorder in the Fentanyl Era—The Role and Limits of Expert Consensus - Takeaways - MDSpire

Hospital-Based Management of Opioid Use Disorder in the Fentanyl Era—The Role and Limits of Expert Consensus

  • By

  • Itai Danovitch

  • May 7, 2026

Share

  • 1

    Illicitly manufactured fentanyl is the leading cause of opioid-involved overdose deaths in the US, complicating treatment for opioid use disorder (OUD).

  • 2

    Expert consensus supports modifying existing protocols for initiating medications for opioid use disorder (MOUD) in hospitalized patients, especially for heavy fentanyl users.

  • 3

    Hospitalized patients with OUD often present with complex medical issues, necessitating individualized treatment approaches rather than strict adherence to protocols.

  • 4

    Monitoring emerging drug contaminants and local prevalence is essential for adapting clinical practices and ensuring effective treatment for OUD in hospitals.

  • 5

    Successful MOUD initiation in hospitals requires effective discharge planning and linkage to ongoing treatment to sustain recovery and reduce mortality.

Original Source(s)

Hospital-Based Management of Opioid Use Disorder in the Fentanyl Era—The Role and Limits of Expert Consensus

  • by Itai Danovitch

  • May 7, 2026

Related Content

Cross-Linked HA Did Not Outperform Saline

Two single-injection cross-linked hyaluronic acid formulations showed no statistically significant advantage over saline for pain or functional outcomes through 24 weeks.

NF-κB signaling in acute myocardial infarction: pathophysiology, inflammation, and therapeutic implications

Are GLP-1s Linked to Optic Neuropathy?

A nationwide Swedish cohort found a higher relative risk of anterior ischemic optic neuropathy among GLP-1 receptor agonist users, but the overall risks were low.